134 related articles for article (PubMed ID: 1523278)
1. Effects of repeated MK-801 on ambulation in mice and in sensitization following methamphetamine.
Kuribara H; Asami T; Ida I; Iijima Y; Tadokoro S
Psychopharmacology (Berl); 1992; 108(3):271-5. PubMed ID: 1523278
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice.
Ida I; Asami T; Kuribara H
Jpn J Pharmacol; 1995 Oct; 69(2):83-90. PubMed ID: 8569058
[TBL] [Abstract][Full Text] [Related]
3. Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice.
Iijima Y; Asami T; Kuribara H
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):11-8. PubMed ID: 8640458
[TBL] [Abstract][Full Text] [Related]
4. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine.
Ohmori T; Abekawa T; Muraki A; Koyama T
Pharmacol Biochem Behav; 1994 Jul; 48(3):587-91. PubMed ID: 7938110
[TBL] [Abstract][Full Text] [Related]
5. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
6. MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice.
Kim HS; Jang CG
Brain Res Bull; 1997; 44(3):221-7. PubMed ID: 9323434
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice.
Ohno M; Watanabe S
Eur J Pharmacol; 1995 Feb; 275(1):39-44. PubMed ID: 7539765
[TBL] [Abstract][Full Text] [Related]
8. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine blocks repeated high-dose methamphetamine-induced behavioral sensitization to dizocilpine (MK-801), but not methamphetamine in rats.
Nakato Y; Abekawa T; Inoue T; Ito K; Koyama T
Neurosci Lett; 2011 Oct; 504(2):131-134. PubMed ID: 21945544
[TBL] [Abstract][Full Text] [Related]
10. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
Muraki A
Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
[TBL] [Abstract][Full Text] [Related]
11. [Effects of repeated administration of bromocriptine on ambulatory activity in mice, and changes in methamphetamine sensitivity in bromocriptine-experienced mice].
Asami T; Kuribara H; Tadokoro S
Yakubutsu Seishin Kodo; 1986 Sep; 6(3):309-17. PubMed ID: 3811623
[TBL] [Abstract][Full Text] [Related]
12. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Aug; 187(3):293-302. PubMed ID: 16850286
[TBL] [Abstract][Full Text] [Related]
13. Effect of the protein kinase C inhibitor, staurosporine, on the high dose of methamphetamine-induced behavioral sensitization to dizocilpine (MK-801).
Fang YR; Abekawa T; Li XB; Wang ZC; Inoue T; Koyama T
Psychopharmacology (Berl); 2005 Jun; 180(1):100-6. PubMed ID: 15682296
[TBL] [Abstract][Full Text] [Related]
14. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
[TBL] [Abstract][Full Text] [Related]
15. Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization.
Ujike H; Tsuchida H; Kanzaki A; Akiyama K; Otsuki S
Life Sci; 1992; 50(22):1673-81. PubMed ID: 1534132
[TBL] [Abstract][Full Text] [Related]
16. MK-801 prevents the development of behavioral sensitization during repeated morphine administration.
Jeziorski M; White FJ; Wolf ME
Synapse; 1994 Feb; 16(2):137-47. PubMed ID: 8197575
[TBL] [Abstract][Full Text] [Related]
17. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats.
Layer RT; Kaddis FG; Wallace LJ
Pharmacol Biochem Behav; 1993 Jan; 44(1):245-7. PubMed ID: 8430127
[TBL] [Abstract][Full Text] [Related]
18. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
Criswell HE; Johnson KB; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
[TBL] [Abstract][Full Text] [Related]
19. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
[TBL] [Abstract][Full Text] [Related]
20. Caffeine enhances the stimulant effect of methamphetamine, but may not affect induction of methamphetamine sensitization of ambulation in mice.
Kuribara H
Psychopharmacology (Berl); 1994 Oct; 116(2):125-9. PubMed ID: 7862940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
